Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 9

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients

Total article views   HTML views PDF downloads Totals
12,489 Dovepress* 10,488+ 2,143 12,631
PubMed Central* 2,001 425 2,426
Totals 12,489 2,568 15,057
*Since 24 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar